Sequenom Stock Hits New 52-Week Low (SQNM)

NEW YORK ( TheStreet) -- Sequenom (Nasdaq: SQNM) hit a new 52-week low Tuesday as it is currently trading at $3.55, below its previous 52-week low of $3.57 with 2.7 million shares traded as of 2:15 p.m. ET. Average volume has been 2.5 million shares over the past 30 days.

Sequenom has a market cap of $414.2 million and is part of the health care sector and drugs industry. Shares are down 14.8% year to date as of the close of trading on Monday.

Sequenom, Inc. provides products, services, diagnostic testing, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural and livestock research.

TheStreet Ratings rates Sequenom as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full Sequenom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens